California 2021-2022 Regular Session

California Assembly Bill AB1627

Introduced
1/11/22  
Introduced
1/11/22  
Refer
1/20/22  
Refer
1/20/22  
Report Pass
3/24/22  
Report Pass
3/24/22  
Refer
3/28/22  
Refer
3/28/22  
Report Pass
3/30/22  
Refer
4/4/22  
Report Pass
4/21/22  
Report Pass
4/21/22  
Refer
4/25/22  
Refer
4/25/22  
Refer
4/25/22  
Refer
5/11/22  
Refer
5/11/22  
Report Pass
5/19/22  
Report Pass
5/19/22  
Engrossed
5/25/22  
Engrossed
5/25/22  
Refer
5/26/22  
Refer
5/26/22  
Refer
6/1/22  
Report Pass
6/20/22  
Report Pass
6/20/22  
Refer
6/20/22  
Refer
6/20/22  
Report Pass
6/30/22  
Report Pass
6/30/22  
Refer
6/30/22  
Refer
6/30/22  
Refer
8/2/22  

Caption

Opioid overdose prevention.

Impact

The bill represents a proactive response to the opioid crisis affecting many communities in California. By implementing a pilot project that not only provides naloxone but also includes training for community members, AB 1627 seeks to reduce the number of opioid-related overdoses and fatalities. Data collection on overdose rates and emergency department visits is also mandated, which will provide valuable insights into the program's effectiveness and inform future public health policies. The provisions in the bill allow local health departments and community organizations to play a pivotal role in overdose prevention efforts.

Summary

Assembly Bill 1627, introduced by Assembly Member Ramos and co-authored by several legislative members, addresses the critical issue of opioid overdose prevention in California. The legislation specifically mandates the establishment of a pilot program within the Counties of San Bernardino, Riverside, and Orange. The program aims to provide an opioid antagonist, approved by the FDA, free of charge to individuals who undergo training on its administration. This pilot project is set to run until January 1, 2025, and aims to equip at-risk populations with essential tools to prevent overdoses effectively.

Sentiment

The sentiment surrounding AB 1627 has been largely positive, particularly among public health advocates, who view the bill as essential in combating the opioid epidemic. Legislators and advocates argue that by extending access to life-saving medication and creating awareness about opioid risks, the bill has the potential to save lives. However, there are concerns about the funding and resources necessary to execute these initiatives effectively, as well as the need for ongoing support beyond the pilot program's timeline.

Contention

Despite the broad support, there are points of contention regarding the sustainability of the program and the adequacy of the funding allocated. Critics have raised questions about the long-term impact of a pilot program that is set to expire, and whether further legislative action will be necessary to ensure that overdose prevention efforts continue in the long run. Additionally, the focus on only a few counties has led to discussions about equity in access to overdose prevention resources throughout the state.

Companion Bills

No companion bills found.

Similar Bills

CA AB462

Overdose response teams.

CA AB1233

Substance abuse: Naloxone Distribution Project: tribal governments.

CO HB1326

Fentanyl Accountability And Prevention

CA AB915

Pupil health: drug education: opioid overdose training program.

CA AB1037

Public health: substance use disorder.

CA AB1915

Pupil health: drug education: opioid overdose training program.

CA SB997

Pupil health: opioid antagonists and fentanyl test strips.